Hope for muscle stiffness: new drug shows promise in Long-Term trial
Symptom relief
ENROLLING_BY_INVITATION
This study looks at the long-term safety and effectiveness of a daily medication called mexiletine PR for reducing muscle stiffness (myotonia) in people with myotonic dystrophy types 1 and 2. It is for those who have already completed a previous study of the same drug. The goal i…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC